Compugen Net Debt / EBITDA
The Net Debt to EBITDA of Compugen (CGEN) as of Sep 7, 2026 is -4.65. In the previous year, Net Debt to EBITDA was 6.93 — a change of -167.05% (lower).
Get this data via API
Financial Data API
Net Debt / EBITDA
-4.65
YoY
-167.05%
Last updated:
The Compugen Net Debt / EBITDA history
3 Years
10 Years
25 Years
Max
| YEAR | Net Debt / EBITDA | YoY |
|---|---|---|
| -4.65 | -167.05% | |
| 6.93 | +77.74% | |
| 3.90 | +65.58% | |
| 2.36 | -29.40% | |
| 3.34 | -15.07% | |
| 3.93 | +158.62% | |
| 1.52 | -22.73% | |
| 1.97 | +141.66% | |
| 0.81 | -56.91% | |
| 1.89 | -51.74% | |
| 3.91 | -34.50% | |
| 5.97 | +117.70% | |
| 2.74 | +89.69% | |
| 1.45 | +196.41% | |
| 0.49 | -47.33% | |
| 0.93 | -53.30% | |
| 1.98 | +372.48% | |
| 0.42 | +269.57% | |
| 0.11 | -87.33% | |
| 0.90 | — |
Compugen Stock analysis
Frequently Asked Questions about Compugen stock
Net Debt to EBITDA of Compugen is -4.65 in 2026.
Net Debt to EBITDA of Compugen changed from 6.93 to -4.65, representing a -167.05% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Net Debt to EBITDA Compugen since 2006 – with annual values, charts, and detailed analysis.
Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Compugen with sector peers and the industry average to assess whether it is attractive.
Leverage — Compugen
All Key Metrics — Compugen
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth